Detalles de la búsqueda
1.
KEYNOTE-434 part B: A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non-small-cell lung cancer.
Invest New Drugs;
2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38530565
2.
Current diagnosis and treatment of salivary gland-type tumors of the lung.
Jpn J Clin Oncol;
54(3): 229-247, 2024 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38018262
3.
First-in-human study of ONO-4578, an antagonist of prostaglandin E2 receptor 4, alone and with nivolumab in solid tumors.
Cancer Sci;
114(1): 211-220, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36082616
4.
Pharmacokinetic and dose-finding study of osimertinib in patients with impaired renal function and low body weight.
Cancer Sci;
114(5): 2087-2097, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36704833
5.
Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan.
Int J Clin Oncol;
28(12): 1585-1596, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37787866
6.
Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022.
Int J Clin Oncol;
28(10): 1315-1332, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37453935
7.
Phase I Study of Tremelimumab Monotherapy or in Combination With Durvalumab in Japanese Patients With Advanced Solid Tumors or Malignant Mesothelioma.
Oncologist;
27(9): e703-e722, 2022 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35671201
8.
Evaluation of hepatic CYP3A enzyme activity using endogenous markers in lung cancer patients treated with cisplatin, dexamethasone, and aprepitant.
Eur J Clin Pharmacol;
78(4): 613-621, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35039908
9.
First-in-human study of the cancer peptide vaccine TAS0313 in patients with advanced solid tumors.
Cancer Sci;
112(4): 1514-1523, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33615628
10.
Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study.
Cancer Sci;
112(6): 2361-2370, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33686772
11.
Radiographic features and poor prognostic factors of interstitial lung disease with nivolumab for non-small cell lung cancer.
Cancer Sci;
112(4): 1495-1505, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33098725
12.
Treatment and relapse of interstitial lung disease in nivolumab-treated patients with non-small cell lung cancer.
Cancer Sci;
112(4): 1506-1513, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33125784
13.
The safety and tolerability of epacadostat alone and in combination with pembrolizumab in patients with advanced solid tumors: results from a first-in-Japanese phase I study (KEYNOTE-434).
Invest New Drugs;
39(1): 152-162, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32564277
14.
Brigatinib and lorlatinib: their effect on ALK inhibitors in NSCLC focusing on resistant mutations and central nervous system metastases.
Jpn J Clin Oncol;
51(1): 37-44, 2021 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33147606
15.
Results of the non-small cell lung cancer part of a phase III, open-label, randomized trial evaluating topical corticosteroid therapy for facial acneiform dermatitis induced by EGFR inhibitors: stepwise rank down from potent corticosteroid (FAEISS study, NCCH-1512).
Support Care Cancer;
29(5): 2327-2334, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32918131
16.
Exacerbation of atrioventricular block associated with concomitant use of amlodipine and aprepitant in a lung cancer patient: A case report.
Int J Clin Pharmacol Ther;
59(4): 328-332, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33355084
17.
Five-year safety and efficacy data from a phase Ib study of nivolumab and chemotherapy in advanced non-small-cell lung cancer.
Cancer Sci;
111(6): 1933-1942, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32277531
18.
First-in-human phase I study of E7090, a novel selective fibroblast growth factor receptor inhibitor, in patients with advanced solid tumors.
Cancer Sci;
111(2): 571-579, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31797489
19.
Phase I Study of the Bifunctional Fusion Protein Bintrafusp Alfa in Asian Patients with Advanced Solid Tumors, Including a Hepatocellular Carcinoma Safety-Assessment Cohort.
Oncologist;
25(9): e1292-e1302, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32324927
20.
Predictive value of serum VEGF levels for elderly patients or for patients with poor performance status receiving anti-PD-1 antibody therapy for advanced non-small-cell lung cancer.
Cancer Immunol Immunother;
69(7): 1229-1236, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32152703